UBS Group’s Bon Natural Life BON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59 Sell
46
-654
-93% -$1.04K ﹤0.01% 10186
2025
Q4
$1.11K Buy
+700
New +$1.3K ﹤0.01% 9698
2025
Q3
Sell
-12,920
Closed -$16.1K 10354
2025
Q2
$16.1K Buy
+12,920
New +$20.1K ﹤0.01% 8580
2024
Q3
Sell
-2,758
Closed -$167K 9517
2024
Q2
$167K Buy
2,758
+2,757
+275,700% +$213K ﹤0.01% 5791
2024
Q1
$62 Buy
+1
New +$124 ﹤0.01% 8901
2023
Q4
Hold
0
-$46 9330
2023
Q3
Sell
-28
Closed -$4.01K 9017
2023
Q2
$4.13K Buy
28
+5
+22% +$1.06K ﹤0.01% 7564
2023
Q1
$8.24K Sell
23
-17
-43% -$6.48K ﹤0.01% 7742
2022
Q4
$10.6K Buy
40
+18
+82% +$6K ﹤0.01% 8490
2022
Q3
$12K Buy
22
+13
+144% +$6.46K ﹤0.01% 8145
2022
Q2
$6K Buy
9
+5
+125% +$5.11K ﹤0.01% 8656
2022
Q1
$3K Sell
4
-7
-64% -$6.53K ﹤0.01% 9425
2021
Q4
$12K Buy
+11
New +$15.9K ﹤0.01% 8547
2021
Q3
Sell
-21
Closed -$36K 9549
2021
Q2
$36K Buy
+21
New +$38.2K ﹤0.01% 6739

Other funds holding BON

UBS Group's BON Position: Q1 2026 in Review

UBS Group reduced its Bon Natural Life (BON) stake by 93% in Q1 2026, selling an estimated $1.04K and leaving 46 shares worth $59. The position accounts for ﹤0.01% of the portfolio, ranked #10186.

UBS Group first reported a position in BON in Q2 2021 and has held it in 13 quarters since. The position peaked at $167K in Q2 2024. 4 funds tracked by Wall St. Rank hold BON as of Q1 2026.

  • UBS Group held 46 shares of Bon Natural Life worth $59 as of Q1 2026.
  • UBS Group sold 654 Bon Natural Life shares in Q1 2026, an estimated $1.04K.
  • Bon Natural Life made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10186 holding.
  • UBS Group first reported a position in Bon Natural Life in Q2 2021 and has held it in 13 quarters since.
  • UBS Group's Bon Natural Life position peaked at $167K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Bon Natural Life as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.